IRF1 and breast cancer: Pathways including epithelial to mesenchyme transition (EMT), apical junction, angiogenesis, and coagulation regulation were modulated with IRF1 downregulation in the HER2+ breast cancer FB2 fibroblast cell cluster (Table 3).